Download PDF
Semin Neurol 2006; 26(1): 108-116
DOI: 10.1055/s-2006-933314
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Current Understanding of Multiple Risk Factors as the Metabolic Syndrome: Distillation or Deconstruction

Bernadette Boden-Albala1
  • 1Department of Neurology and Department of Sociomedical Science, Neurological Institute, New York, New York
Further Information

Publication History

Publication Date:
15 February 2006 (online)

    Permissions and Reprints

ABSTRACT

The “metabolic syndrome” is a new term that defines the clustering of vascular risk factors, such as hyperlipidemia, obesity, elevated blood pressure, and elevated blood glucose. Controversy exists regarding the use of the term, which raises the question of whether the unique grouping of vascular risk factors adds more clinical risk then the additive effect of multiple risk factors viewed as separate but important entities. Whatever the answer, the metabolic syndrome constitutes a major public health problem with over 47 million persons in the United States meeting criteria for the metabolic syndrome. Although studies have demonstrated that the metabolic syndrome is a risk factor for overall mortality as well as cardiovascular events, the relationship between the metabolic syndrome and ischemic stroke has not been well characterized. Two large cross-sectional studies report an association between metabolic syndrome and increased risk of a history of stroke. One large multiethnic prospective study found the metabolic syndrome to be significantly associated with an increased risk of ischemic stroke after adjustment for sociodemographics and other cardiovascular risk factors. This study estimated that the metabolic syndrome may account for 19% of ischemic strokes including 30% of stroke in women and over 40% of stroke in Hispanics. Despite debate about the utility of its definition, there is evidence to suggest that the metabolic syndrome is an important risk factor for ischemic stroke, with differential effects by gender and race-ethnicity. Further, the metabolic syndrome has important clinical and public health implications by helping to easily identify individuals at greatest risk of vascular events.

KEYWORDS

Metabolic syndrome - stroke risk factors - insulin resistance

REFERENCES

  • 1 Sacco R. Stroke risk factors: an overview. In: Norris JW Stroke Prevention. New York; Oxford University Press 2001: 17-42
    Google Scholar
  • 2 Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.  JAMA. 2002;  287 356-359
    CrossrefPubMedGoogle Scholar
  • 3 Haffner S, Taegtmeyer M. Epidemic obesity and the metabolic syndrome.  Circulation. 2003;  108 1541-1545
    CrossrefPubMedGoogle Scholar
  • 4 Ferrannini E, Balkau B. Insulin: in search of a syndrome.  Diabet Med. 2002;  19 724-729
    CrossrefPubMedGoogle Scholar
  • 5 Lakka H, Laaksonen D, Lakka T et al.. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.  JAMA. 2002;  288 2709-2716
    CrossrefPubMedGoogle Scholar
  • 6 Reaven G. Banting Lecture 1988: role of insulin resistance in human disease.  Diabetes. 1988;  37 1595-1607
    CrossrefPubMedGoogle Scholar
  • 7 Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome.  Circulation. 2003;  108 1541-1545
    CrossrefPubMedGoogle Scholar
  • 8 Hanley A, Karter A, Festa A et al.. Insulin resistance and atherosclerosis study.  Diabetes. 2002;  51 2642-2647
    PubMedGoogle Scholar
  • 9 World Health Organization .Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Geneva, Switzerland; Department of Noncommunicable Disease Surveillance, World Health Organization 1999
    Google Scholar
  • 10 Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III).  JAMA. 2001;  285 2486-2497
    CrossrefPubMedGoogle Scholar
  • 11 Ford E, Giles W, Mokdad A. Increasing prevalence of the metabolic syndrome among US adults.  Diabetes Care. 2004;  27 2444-2449
    CrossrefPubMedGoogle Scholar
  • 12 Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.  Arch Pediatr Adolesc Med. 2003;  157 821-827
    CrossrefPubMedGoogle Scholar
  • 13 Duncan G, Li S, Zhou X. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999-2000.  Diabetes Care. 2004;  27 2438-2443
    CrossrefPubMedGoogle Scholar
  • 14 Scott C L. Diagnosis, prevention, and intervention for the metabolic syndrome.  Am J Cardiol. 2003;  92 35i-42i
    CrossrefPubMedGoogle Scholar
  • 15 Boden-Albala B, Lee H, Sacco R L. Stroke risk and the metabolic syndrome: findings from the Northern Manhattan Stroke Study.  Neurology. 2003;  60 A255
    PubMedGoogle Scholar
  • 16 Meigs J B, Wilson P W, Nathan D M, D'Agostino Sr R B, Williams K, Haffner S M. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.  Diabetes. 2003;  52 2160-2167
    PubMedGoogle Scholar
  • 17 Lin H F, Boden-Albala B, Juo S H, Park N, Rundek T, Sacco R L. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.  Diabetologia. 2005;  48 2006-2012
    CrossrefPubMedGoogle Scholar
  • 18 Sacco R L, Boden-Albala B, Abel G et al.. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke Study.  Stroke. 2001;  32 1725-1731
    PubMedGoogle Scholar
  • 19 Fernandez J, Allison D. Understanding racial differences in obesity and metabolic syndrome traits.  Nutr Rev. 2003;  61 316-320
    CrossrefPubMedGoogle Scholar
  • 20 Haffner S, Gonzalez Villalpando C, Hazuda H P, Valdez R, Mykkanen L, Stern M. Prevalence of hypertension in Mexico City and San Antonio, Texas.  Circulation. 1994;  90 1542-1549
    PubMedGoogle Scholar
  • 21 Despres J P, Lamarche B, Mauriege P et al.. Hyperinsulinemia as an independent risk factor for ischemic heart disease.  N Engl J Med. 1996;  334 952-957
    CrossrefPubMedGoogle Scholar
  • 22 Denke M. Connections between obesity and dyslipidemia.  Curr Opin Lipidol. 2001;  12 625-628
    CrossrefPubMedGoogle Scholar
  • 23 Hsia J, Bittner V, Tripputi M, Howard B V. Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen Trial.  Am Heart J. 2003;  146 439-445
    CrossrefPubMedGoogle Scholar
  • 24 Lapidus L, Bengstsson C, Larsson B et al.. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden.  Br Med J (Clin Res Ed). 1984;  289 1257-1261
    PubMedGoogle Scholar
  • 25 Ducimetiere P, Eschwege E, Papoz L, Richard J L, Claude J R, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.  Diabetologia. 1980;  19 205-210
    CrossrefPubMedGoogle Scholar
  • 26 Folsom A R, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt J H. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.  Diabetes Care. 1997;  20 935-942
    PubMedGoogle Scholar
  • 27 Klein B, Klein R, Lee K. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.  Diabetes Care. 2002;  25 1790-1794
    CrossrefPubMedGoogle Scholar
  • 28 Ninomiya J, L'Italian G, Criqui M, Whyte J. Association of the metabolic syndrome with a history and stroke in the Third National Health and Nutrition Examination Survey.  Circulation. 2004;  109 42-46
    CrossrefPubMedGoogle Scholar
  • 29 Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki policemen study.  Stroke. 1998;  29 1860-1866
    PubMedGoogle Scholar
  • 30 Hu G, Qiao Q, Tuomilehto J et al.. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women.  Arch Intern Med. 2004;  164 1066-1076
    CrossrefPubMedGoogle Scholar
  • 31 Ridker P M, Bassuk S S, Toth P P. C-reactive protein and risk of cardiovascular disease: evidence and clinical application.  Curr Atheroscler Rep. 2003;  5 341-349
    PubMedGoogle Scholar
  • 32 Ridker P, Buring J, Cook N, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women.  Circulation. 2003;  107 391-397
    CrossrefPubMedGoogle Scholar
  • 33 Hu G, Qiao Q, Tuomilehto J. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women.  Arch Intern Med. 2004;  164 1066-1076
    CrossrefPubMedGoogle Scholar
  • 34 Wilson P, Kannel W, Silbershatz H, D'Agostino R. Clustering of metabolic factors and coronary heart disease.  Arch Intern Med. 1999;  159 1104-1109
    CrossrefPubMedGoogle Scholar
  • 35 Sprecher D L, Pearce G L. How deadly is the “deadly quartet”? A post CABG evaluation.  J Am Coll Cardiol. 2000;  36 1159-1165
    PubMedGoogle Scholar
  • 36 Isomaa B, Almgren P, Tuomi T et al.. Cardiovascular morbidity and mortality associated with the metabolic syndrome.  Diabetes Care. 2001;  24 683-689
    CrossrefPubMedGoogle Scholar
  • 37 Pyorala K, Ballantyne C, Gumbiner B et al.. Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome.  Diabetes Care. 2004;  27 1735-1740
    PubMedGoogle Scholar
  • 38 Li W, Girard P, Boissel J, Gueyffier F. The calculation of a confidence interval on the absolute estimated benefit for an individual patient.  Comput Biomed Res. 1998;  31 244-256
    CrossrefPubMedGoogle Scholar
  • 39 Poulsen P. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins.  Diabetologia. 2001;  44 537-543
    CrossrefPubMedGoogle Scholar
  • 40 Freeman M. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families.  Diabet Med. 2002;  19 994-999
    CrossrefPubMedGoogle Scholar
  • 41 Olswold C, de Andrade M. Localization of genes involved in the metabolic syndrome using multivariate linkage analysis.  BMC Genet. 2003;  4(suppl 1) S57
    CrossrefPubMedGoogle Scholar
  • 42 Edwards K L, Newman B, Mayer E, Selby J V, Krauss R M, Austin M A. Heritability of factors of the insulin resistance syndrome in women twins.  Genet Epidemiol. 1997;  14 241-253
    CrossrefPubMedGoogle Scholar
  • 43 Brook R D, Glazewski L, Rajagopalan S, Bard R L. Hypertension and triglyceride catabolism: implications for the hemodynamic model of the metabolic syndrome.  J Am Coll Nutr. 2003;  22 290-295
    PubMedGoogle Scholar
  • 44 Folsom A R, Rasmussen M L, Chambless L E et al.. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study Investigators.  Diabetes Care. 1999;  22 1077-1083
    PubMedGoogle Scholar
  • 45 Howard G, O'Leary D H, Zaccaro D et al.. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators.  Circulation. 1996;  93 1809-1817
    PubMedGoogle Scholar
  • 46 Kernan W N, Inzucchi S E, Viscoli C M, Brass L M, Bravata D M, Horwitz R I. Insulin resistance and risk for stroke.  Neurology. 2002;  59 809-815
    PubMedGoogle Scholar
  • 47 Sakkinen P A, Wahl P, Cushman M, Lewis M R, Tracy R P. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.  Am J Epidemiol. 2000;  152 897-907
    CrossrefPubMedGoogle Scholar
  • 48 Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans.  J Clin Invest. 1994;  94 2511-2515
    CrossrefPubMedGoogle Scholar
  • 49 Weiss R, Dziura J, Burgert T et al.. Obesity and the metabolic syndrome in children and adolescents.  N Engl J Med. 2004;  350 2362-2374
    CrossrefPubMedGoogle Scholar
  • 50 Blake G, Ridker P. Inflammatory bio-markers and cardiovascular risk prediction.  J Intern Med. 2002;  252 283-294
    CrossrefPubMedGoogle Scholar
  • 51 Grundy S, Hansen B, Smith S. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.  Circulation. 2004;  109 551-556
    CrossrefPubMedGoogle Scholar
  • 52 Wong N D, Pio J R, Franklin S S, L'Italien G J, Kamath T V, Williams G R. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome.  Am J Cardiol. 2003;  91 1421-1426
    CrossrefPubMedGoogle Scholar
  • 53 Malik S, Wong N D, Franklin S et al.. Impact of metabolic syndrome on mortality from coronary artery disease, cardiovascular disease, and all causes in United States.  Circulation. 2004;  110 1245-1250
    CrossrefPubMedGoogle Scholar
  • 54 Ferrannini E, Balkau B. Insulin: in search of a syndrome.  Diabet Med. 2002;  19 724-729
    CrossrefPubMedGoogle Scholar
  • 55 Meigs J B, Mittleman M A, Nathan D M et al.. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.  JAMA. 2000;  283 221-228
    CrossrefPubMedGoogle Scholar
  • 56 Meigs J B. The metabolic syndrome.  BMJ. 2003;  327 61-62
    CrossrefPubMedGoogle Scholar
  • 57 Najarian R M, Sullivan L M, Kannel W B, Wilson P WF, D'agostino R B, Wolf P A. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke.  Arch Intern Med. 2006;  166 106-111
    CrossrefPubMedGoogle Scholar
  • 58 Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.  Stroke. 1998;  29 1860-1866
    PubMedGoogle Scholar

Bernadette Boden-AlbalaDr. P.H. 

Neurological Institute, 710 West 168 Street

New York, NY 10032

      >